Latest News about George Tziras
Recent news which mentions George Tziras
This Novel Short-Acting Psychedelic Compound Is Ready For First Phase 1 Clinical Try-Out
October 31, 2022
From Benzinga
This Pharma Company Just Scored Another Psychedelics Patent And Set Its Sights On 70 More
October 19, 2022
Tickers
DMTTF
From Benzinga
Small Pharma: New Canadian Patent For Proprietary DMT Analogue, Adds To Growing International Protection Grants
August 03, 2022
Tickers
DMTTF
From Benzinga
Small Pharma Obtains U.S. Patent For Injectable DMT, First In Company's Psychedelic Portfolio
July 26, 2022
Tickers
DMTTF
From Benzinga